Guangdong Kanghua Healthcare Group's (HKG:3689) Earnings Seem To Be Promising

The market seemed underwhelmed by last week's earnings announcement from Guangdong Kanghua Healthcare Group Co., Ltd. (HKG:3689) despite the healthy numbers. We did some digging, and we think that investors are missing some encouraging factors in the underlying numbers.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Examining Cashflow Against Guangdong Kanghua Healthcare Group's Earnings

One key financial ratio used to measure how well a company converts its profit to free cash flow (FCF) is the accrual ratio. To get the accrual ratio we first subtract FCF from profit for a period, and then divide that number by the average operating assets for the period. You could think of the accrual ratio from cashflow as the 'non-FCF profit ratio'.

That means a negative accrual ratio is a good thing, because it shows that the company is bringing in more free cash flow than its profit would suggest. That is not intended to imply we should worry about a positive accrual ratio, but it's worth noting where the accrual ratio is rather high. Notably, there is some academic evidence that suggests that a high accrual ratio is a bad sign for near-term profits, generally speaking.

Guangdong Kanghua Healthcare Group has an accrual ratio of -0.13 for the year to December 2025. That indicates that its free cash flow was a fair bit more than its statutory profit. In fact, it had free cash flow of CN¥234m in the last year, which was a lot more than its statutory profit of CN¥99.6m. Guangdong Kanghua Healthcare Group's free cash flow improved over the last year, which is generally good to see.

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Guangdong Kanghua Healthcare Group.

Our Take On Guangdong Kanghua Healthcare Group's Profit Performance

As we discussed above, Guangdong Kanghua Healthcare Group has perfectly satisfactory free cash flow relative to profit. Because of this, we think Guangdong Kanghua Healthcare Group's earnings potential is at least as good as it seems, and maybe even better! Furthermore, it has done a great job growing EPS over the last year. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. You'd be interested to know, that we found 2 warning signs for Guangdong Kanghua Healthcare Group and you'll want to know about these bad boys.

This note has only looked at a single factor that sheds light on the nature of Guangdong Kanghua Healthcare Group's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.